1-5 of 5
Qinglei Gao
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)

Qinglei Gao, Jianqing Zhu, Weidong Zhao, Yi Huang, Ruifang An, Hong Zheng, Pengpeng Qu, Li Wang, Qi Zhou, Danbo Wang, Ge Lou, Jing Wang, Ke Wang, John Low, Beihua Kong, Abdul Malik Rozita, Lim Chun Sen, Rutie Yin, Xing Xie, Jihong Liu, Wei Sun, Jingya Su, Chunyi Zhang, Rongyu Zang, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (11): 2278–2285.
https://doi.org/10.1158/1078-0432.CCR-21-3023
Published: 01 June 2022
View article titled, Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA)
Open the PDF for Olaparib Maintenance Monotherapy in Asian Patients with Platinum-Sensitive Relapsed Ovarian Cancer: Phase III Trial (L-MOCA) in another window
Includes: Supplementary data
Journal Articles

Pamiparib Monotherapy for Patients with Germline BRCA1/2-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study

Xiaohua Wu, Jianqing Zhu, Jing Wang, Zhongqiu Lin, Rutie Yin, Wei Sun, Qi Zhou, Songling Zhang, Danbo Wang, Hong Shi, Yunong Gao, Yi Huang, Guiling Li, Xiuli Wang, Ying Cheng, Ge Lou, Qinglei Gao, Li Wang, Xiuping Du, Mei Pan, Xiyan Mu, Li Li, Miao Li, Song Mu, Beihua Kong
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (4): 653–661.
https://doi.org/10.1158/1078-0432.CCR-21-1186
Published: 15 February 2022
View article titled, Pamiparib Monotherapy for Patients with Germline <em>BRCA1/2</em>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study
Open the PDF for Pamiparib Monotherapy for Patients with Germline <em>BRCA1/2</em>-Mutated Ovarian Cancer Previously Treated with at Least Two Lines of Chemotherapy: A Multicenter, Open-Label, Phase II Study in another window
Includes: Supplementary data
Journal Articles

Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability

Jianfeng Zhou, Qinglei Gao, Gang Chen, Xiaoyuan Huang, Yunping Lu, Kanyan Li, Daxing Xie, Liang Zhuang, Jingniu Deng, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (24): 7611.
https://doi.org/10.1158/1078-0432.CCR-19-3370
Published: 13 December 2019
View article titled, Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability
Open the PDF for Correction: Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability in another window
Journal Articles

Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma

Ning Li, Jianfeng Zhou, Danhui Weng, Chenghua Zhang, Lixin Li, Beibei Wang, Yang Song, Qiang He, Dongdong Lin, Dazhi Chen, Gang Chen, Qinglei Gao, Shixuan Wang, Gang Xu, Li Meng, YunPing Lu, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19): 5847–5854.
https://doi.org/10.1158/1078-0432.CCR-07-0499
Published: 01 October 2007
View article titled, Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma
Open the PDF for Adjuvant Adenovirus-Mediated Delivery of Herpes Simplex Virus Thymidine Kinase Administration Improves Outcome of Liver Transplantation in Patients with Advanced Hepatocellular Carcinoma in another window
Journal Articles

Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability

Jianfeng Zhou, Qinglei Gao, Gang Chen, Xiaoyuan Huang, Yunping Lu, Kanyan Li, Daxing Xie, Liang Zhuang, Jingniu Deng, Ding Ma
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (23): 8431–8440.
https://doi.org/10.1158/1078-0432.CCR-05-1085
Published: 01 December 2005
View article titled, Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability
Open the PDF for Novel Oncolytic Adenovirus Selectively Targets Tumor-Associated Polo-Like Kinase 1 and Tumor Cell Viability in another window